PEPFAR’s ‘Global Pediatric ARV Commitment-To-Action’ Aims To Improve Drug Access

U.S. Department of State’s “DipNote”: Accelerating Access to Innovation and Saving Children’s Lives
U.S. Global AIDS Coordinator Ambassador Deborah Birx, Colleen Chien, senior adviser to the CTO at the White House Office of Science and Technology Policy, and Tom Kalil, deputy director for technology and innovation at the OSTP, discuss “PEPFAR’s ‘Global Pediatric Antiretroviral (ARV) Commitment-to-Action,’ which aims to accelerate the development and supply of child-friendly ARV medicines in low- and middle-income countries…” (12/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.